In-silico investigation suggested a common variant within stem of miR-146a-5p precursor (rs2910164, n.60C>G) associated with breast cancer (BC) phenotypes. Our aim was computationally predicting possible targets of miR-146a-5p and probable rs2910164 mechanism of action in expression of phenotypes in BC. Additionally, a case-control study was designated to examine experimentally the correlation of mir-146a rs2910164 variant and BC phenotypes. In this study, 152 BC subjects and healthy controls were genotyped using RFLP-PCR. Allelic and genotypic association and Armitage's trend tests were run to investigate the correlation between the alleles and genotypes and expressed phenotypes of BC. Bioinformatics analyses introduce regulatory function of miR-146a-5p in numerous signaling pathways and impact of allele substitution upon mir-146a stem-loop stability. Logistic regression data represented the C allele of rs2910164 (OR = 4.00, p= 0.0037) as the risk allele and associated with Her2-positive phenotype. In a similar vein, data revealed the correlation of the C allele and cancer death less than two years in BC patients (OR = 2.65, p= 0.0217). Ultimately, unconditional logistical regression models suggested log-additive model for inheritance manner of rs2910164 in either Her2 status or BC survival (OR = 5.64, p= 0.0025 and OR = 3.13, p= 0.019, respectively). Using bioinformatics connected association of Her2 status to altered function of miR-146a-5p in regulation of focal adhesion and Ras pathway. Furthermore, computations inferred the association between death phenotype and studied SNP upon specific target genes of miR-146a-5p involved in focal adhesion, EGF receptor, Ras, ErbB, interleukin, Toll-like receptor, NGF, angiogenesis, and p53 feedback loops 2 signaling pathways. These verdicts may enhance our perceptions of how mir-146a rs2910164 affect expressed phenotypes in BC, and might have potential implications to develop BC treatment in future.
ParkinDM. International variation. Oncogene. 2004; 23(38): 6329-40.
2.
Cancer CGoHFiB. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. The Lancet. 2001; 358(9291): 1389-99.
3.
LallooF, EvansD. Familial breast cancer. Clinical Genetics. 2012; 82(2): 105-14.
4.
FilipowiczW, BhattacharyyaSN, SonenbergN. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics. 2008; 9(2): 102-14.
5.
LuJ, GetzG, MiskaEA, Alvarez-SaavedraE, LambJ, PeckD et al. MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043): 834-8.
6.
Mesrian TanhaH, Mojtabavi NaeiniM, RahgozarS, MoafiA, HonardoostMA. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment. Tumor Biology. 2015: PubMed ahead of print.
7.
BhaumikD, ScottG, SchokrpurS, PatilC, CampisiJ, BenzC. Expression of microRNA-146 suppresses NF-κ B activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008; 27(42): 5643-7.
8.
HurstDR, EdmondsMD, ScottGK, BenzCC, VaidyaKS, WelchDR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Research. 2009; 69(4): 1279-83.
9.
CalinGA, CroceCM. MicroRNA signatures in human cancers. Nature Reviews Cancer. 2006; 6(11): 857-66.
10.
PillaiRS. MicroRNA function: multiple mechanisms for a tiny RNA?Rna. 2005; 11(12): 1753-61.
11.
YeagerM, OrrN, HayesRB, JacobsKB, KraftP, WacholderS et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nature Genetics. 2007; 39(5): 645-9.
12.
RyanBM, RoblesAI, McClaryAC, HaznadarM, BowmanED, PineSR et al. Identification of a Functional SNP in the 3' UTR of CXCR2 That Is Associated with Reduced Risk of Lung Cancer. Cancer Research. 2015; 75(3): 566-75.
13.
HuJ, HeH, ZhouH, WangD, WangY, LiuX et al. SNP Affects the Mobility of Breast Cancer Cells and the Expression of Metastasis-Related Genes. Advances in Applied Biotechnology. Springer. 2015: p. 181-8.
14.
LiuC, XuanZ. Prioritization of Cancer-Related Genomic Variants by SNP Association Network. Cancer Informatics. 2015; 14(Suppl 2): 57.
15.
KimG, OuzounovaM, QuraishiA, DavisA, TawakkolN, ClouthierS et al. SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. Oncogene. 2015; 34(6): 671-80.
16.
MenesTS, TerryMB, GoldgarD, AndrulisIL, KnightJA, JohnEM et al. Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry. Breast Cancer research and treatment. 2015: 1-8.
17.
MarjanMN, HamzehMT, RahmanE, SadeqV. A computational prospect to aspirin side effects: Aspirin and COX-1 interaction analysis based on non-synonymous SNPs. Computational Biology and Chemistry. 2014; 51: 57-62.
18.
De GobbiM, ViprakasitV, HughesJR, FisherC, BuckleVJ, AyyubH et al. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science. 2006; 312(5777): 1215-7.
19.
FungKL, PanJ, OhnumaS, LundPE, PixleyJN, Kimchi-SarfatyC et al. MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer. Cancer Research. 2014; 74(2): 598-608.
20.
CroccoP, MontesantoA, PassarinoG, RoseG. Polymorphisms Falling Within Putative miRNA Target Sites in the 3' UTR Region of SIRT2 and DRD2 Genes Are Correlated With Human Longevity. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2015: glv058.
21.
BagheriF, Mesrian TanhaH, Mojtabavi NaeiniM, GhaediK, AzadehM. Tumorpromoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'untranslated region of ErbB4 in breast cancer. Molecular Medicine Reports. 2016; 13(5): 4494-8.
22.
SunG, YanJ, NoltnerK, FengJ, LiH, SarkisDA et al. SNPs in human miRNA genes affect biogenesis and function. Rna. 2009; 15(9): 1640-51.
23.
PastrelloC, PoleselJ, Della PuppaL, VielA, MaestroR. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis. 2010; 31(12): 2124-6.
24.
ZhiH, WangL, MaG, YeX, YuX, ZhuY et al. Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease. Clinical Research in Cardiology. 2012; 101(4): 289-96.
25.
GongJ, TongY, ZhangHM, WangK, HuT, ShanG et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Human Mutation. 2012; 33(1): 254-63.
26.
AnghelA, RaicaM, NaritaD, SeclamanE, NicolaT, UrsoniuS et al. Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer. Neoplasma. 2010; 57(4): 306-15.
27.
BaoL, ZhouM, WuL, LuL, GoldowitzD, WilliamsRW et al. PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Research. 2007; 35(suppl 1): D51-D4.
28.
LianH, WangL, ZhangJ. Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. PLoS One. 2012; 7(2): e31615.
29.
GarciaAI, CoxDG, BarjhouxL, Verny-PierreC, BarnesD, AntoniouAC et al. The rs2910164: G> C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Mutation. 2011; 32(9): 1004-7.
30.
ShenJ, AmbrosoneCB, DiCioccioRA, OdunsiK, LeleSB, ZhaoH. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 2008; 29(10): 1963-6.
31.
HoffmanAE, ZhengT, YiC, LeadererD, WeidhaasJ, SlackF et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Research. 2009; 69(14): 5970-7.
32.
CatucciI, YangR, VerderioP, PizzamiglioS, HeesenL, HemminkiK et al. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. 2010; 31(1): E1052-E7.
33.
Griffiths-JonesS, GrocockRJ, Van DongenS, BatemanA, EnrightAJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research. 2006; 34(suppl 1): D140-D4.
34.
DweepH, StichtC, PandeyP, GretzN. miRWalk-database: prediction of possible miRNA binding sites by ``walking'' the genes of three genomes. Journal of Biomedical Informatics. 2011; 44(5): 839-47.
35.
HsuS-D, TsengY-T, ShresthaS, LinY-L, KhaleelA, ChouC-H et al. miRTarBase update 2014: An information resource for experimentally validated miRNA-target interactions. Nucleic Acids Research. 2014; 42(D1): D78-D85.
36.
HuangDW, ShermanBT, LempickiRA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research. 2009; 37(1): 1-13.
37.
SuX, HuY, LiY, CaoJ-L, WangX-Q, MaX et al. The polymorphism of rs6505162 in miR-423 coding region and recurrent pregnancy loss. Reproduction. 2015: REP- 15-0007.
38.
SlamonDJ, ClarkGM, WongSG, LevinWJ, UllrichA, McGuireWL. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785): 177-82.
ShortSM, YoderBJ, TarrSM, PrescottNL, LaniauskasS, ColemanKA et al. The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: A retrospective immunohistochemical study. The Breast Journal. 2007; 13(2): 130-9.
41.
SchmitzKJ, GrabellusF, CalliesR, OtterbachF, WohlschlaegerJ, LevkauB et al. High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Research. 2005; 7(2): R194.
42.
GarciaAI, BuissonM, BertrandP, RimokhR, RouleauE, LopezBS et al. Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Molecular Medicine. 2011; 3(5): 279-90.
43.
GolubovskayaV, BevigliaL, XuL-H, EarpHS, CravenR, CanceW. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. Journal of Biological Chemistry. 2002; 277(41): 38978-87.
44.
ClarkGJ, DerCJ. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Research and Treatment. 1995; 35(1): 133-44.
45.
HynesNE, MacDonaldG. ErbB receptors and signaling pathways in cancer. Current Opinion in Cell Biology. 2009; 21(2): 177-84.
46.
WaughDJ, WilsonC. The interleukin-8 pathway in cancer. Clinical Cancer Research. 2008; 14(21): 6735-41.
47.
GuoY, XuF, LuT, DuanZ, ZhangZ. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treatment Reviews. 2012; 38(7): 904-10.
48.
DescampsS, ToillonR-A, AdriaenssensE, PawlowskiV, CoolSM, NurcombeV et al. Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. Journal of Biological Chemistry. 2001; 276(21): 17864-70.
49.
HorakE, KlenkN, LeekR, LeJeuneS, SmithK, StuartN et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. The Lancet. 1992; 340(8828): 1120-4.
50.
BertheauP, Lehmann-CheJ, VarnaM, DumayA, PoirotB, PorcherR et al. p53 in breast cancer subtypes and new insights into response to chemotherapy. The Breast. 2013; 22: S27-S9.
51.
WennerbergK, DerCJ. Rho-family GTPases: it's not only Rac and Rho (and I like it). Journal of Cell Science. 2004; 117(8): 1301-12.
52.
BalasenthilS, SahinAA, BarnesCJ, WangR-A, PestellRG, VadlamudiRK et al. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. Journal of Biological Chemistry. 2004; 279(2): 1422-8.
53.
SchneiderSM, OffterdingerM, HuberH, GruntTW. Activation of retinoic acid receptor α is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Research. 2000; 60(19): 5479-87.
